Publicaciones en las que colabora con Luis Sierrasesúmaga Ariznavarreta (9)

2015

  1. A genome-wide scan identifies variants in NFIB associated with metastasis in patients with osteosarcoma

    Cancer Discovery, Vol. 5, Núm. 9, pp. 920-931

  2. Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types

    Journal of the National Cancer Institute, Vol. 107, Núm. 12

  3. Germline TP53 Variants and Susceptibility to Osteosarcoma

    Journal of the National Cancer Institute, Vol. 107, Núm. 7

2014

  1. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33

    Human Molecular Genetics, Vol. 23, Núm. 24, pp. 6616-6633

  2. The oncolytic adenovirus Δ24-RGD in combination with cisplatin exerts a potent anti-osteosarcoma activity

    Journal of Bone and Mineral Research, Vol. 29, Núm. 10, pp. 2287-2296

2013

  1. Genome-wide association study identifies two susceptibility loci for osteosarcoma

    Nature Genetics, Vol. 45, Núm. 7, pp. 799-803

2012

  1. Cortactin (CTTN) overexpression in osteosarcoma correlates with advanced stage and reduced survival

    Cancer Biomarkers, Vol. 10, Núm. 1, pp. 35-41

2009

  1. Profiling of chemonaive osteosarcoma and paired-normal cells identifies EBF2 as a mediator of osteoprotegerin inhibition to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis

    Clinical Cancer Research, Vol. 15, Núm. 16, pp. 5082-5091

2008

  1. CDH11 expression is associated with survival in patients with osteosarcoma

    Cancer Genomics and Proteomics, Vol. 5, Núm. 1, pp. 37-42